|
||
 |
|
|||
|
News February 12, 2010 Please visit our booth at these upcoming 2010 events: Hinman Dental Meeting Christian Medical & Dental Association Tennessee Osteopathic Medical Association April 1, 2009 Visit our booth at The American Academy of Nurse Practitioners 24th National Conference in Nashville, TN, June 18-20, 2009. November 3, 2008 - Panthoderm® Cream samples are now available. Panthoderm® Cream is our non-steroidal, pH balanced, moisturizing, dermatological cream for softer, smoother skin and long-lasting soothing for dry, irritated skin. Click here to order your free sample. March 3, 2008 - Announcing Derma Stat® 1oz sample size We are pleased to announce Derma Stat® anti-microbial waterless hand foam samples are now available. Derma Stat® quickly degerms your hands anytime, anywhere. Its anti-microbial properties meet recommended FDA guidelines for use as a health care personnel hand wash with fast-acting, broad-spectrum anti-microbial activity. 65% ethyl alcohol by volume. To request a sample of Derma Stat® or any of our Derma line of products, click on the Request Samples link to the right of the page. September 10, 2007 -
Rosedale Therapeutics donates Derma Cidol® 2000 to King Rosedale Therapeutics today donated over 700 bottles of Derma Cidol® 2000 Antimicrobial Hand Wash to King Benevolent Fund of Bristol, TN. King Benevolent Fund provides medications and medical supplies to those in need around the world. March 1, 2007 - FDA withdraws unapproved ergotamine drugs from the market The Food and Drug Administration (FDA) today told 20 companies to cease marketing unapproved drug products containing ergotamine tartrate. Ergotamine tartrate products are used to treat vascular headaches, including migraines. As part of the FDA’s continued efforts to combat the marketing of unapproved drugs, the agency sent warning letters to eight manufacturers and 12 distributors warning them that they are subject to further enforcement action if they do not stop manufacturing and distributing these products. The agency urges consumers who are using ergotamine products and have questions or concerns to contact their health care provider. This action does not affect FDA-approved products containing ergotamine, which will remain on the market. “Unapproved drugs pose real risks to the American public,” said Steven Galson, M.D., director of the FDA’s Center for Drug Evaluation and Research (CDER). “Because they have not been subject to FDA review, the safety, effectiveness, and quality of such products are unknown. We remain dedicated to tackling this problem through education and outreach, as well as enforcement actions like these. It is central to our mission to ensure a safe and effective drug supply for the American public.” Read the rest of the FDA action here: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01575.html Ergomar® is the only FDA approved sublingual ergotamine tablet indicated for migraine headaches, and Ergomar® is the only ergotamine tablet without caffeine. To learn more about Ergomar®, click here. February 28, 2007 - Rosedale Therapeutics supports The Face of God Children's Ministry. Nov. 1, 2006 - Rosedale Therapeutics is pleased to announce the purchase of Ergomar® (ergotamine tartrate tablets, USP) and Easprin® (aspirin delayed-release tablets, USP) from Harvest Pharmaceuticals Inc. Ergomar® is indicated as therapy to abort or prevent migraine attacks. See the full prescribing information here. Easprin® is indicated for long-term palliative treatment of mild to moderate pain and inflammation of arthritic and other inflammatory conditions. Full prescribing information is here. Rosedale Therapeutics is a privately held specialty pharmaceutical company headquartered in Bristol, Tennessee. For further information, call (423) 968-5458.
|
|